Press Releases

GlobeNewswire, Inc.

Received U.S. FDA approval and launched RASONQUE® (daraxonrasib) for adult patients with metastatic pancreatic cancer who have received at least one prior systemic therapy or who are not candidates for multiagent systemic therapy Reported RASONQUE...

GlobeNewswire, Inc.

Continued strong ZORYVE® (roflumilast) net product revenue growth, with Q3 revenues of $143.9 million, +45% versus Q3 of 2025, and +11% versus Q2 of 2026, driven by strong demand growth Raised 2026 full-year net product sales guidance to $535...

GlobeNewswire, Inc.

– Commercialization plans for lorundrostat are on track ahead of PDUFA target date of December 22, 2026 – – New analyses from the pivotal Launch-HTN trial showed 46% of participants with uncontrolled or resistant hypertension receiving...

GlobeNewswire, Inc.

MYQORZO® (aficamten) Net Product Revenue of $44.5 Million Expect to Submit Supplemental NDA for Aficamten in Non-Obstructive HCM in Q4 2026 and Type II Variation in the European Union in Early 2027 ~$1.6 Billion in Cash, Cash Equivalents and...

GlobeNewswire, Inc.

- 4WARD Phase 3 Chronic Neutropenia Trial Expected to Achieve Target Enrollment in Q4 2026 - - Initiating 4STEPS Phase 2b Trial Evaluating G-CSF Dose Reduction with Mavorixafor; Enrollment of First Participant Expected in Q1 2027 - - Investor Day...

GlobeNewswire, Inc.

ATLANTA, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Mueller Water Products, Inc. (NYSE: MWA), a leading manufacturer and marketer of products and solutions used in the transmission, distribution and measurement of water in North America, today announced it...

GlobeNewswire, Inc.

VAX-31 Adult Indication: Announced Positive Topline Data from OPUS-1 Pivotal Phase 3 Trial; VAX-31 Met All Prespecified Primary Endpoints, Was Well Tolerated and Demonstrated a Safety Profile Similar to PCV20 and PCV21 Across All Ages Studied...

GlobeNewswire, Inc.

Announced updated clinical data in more than 80 patients from the ongoing PiNACLE pivotal trial in patients with 3L+ R/R LBCL and from the Phase 1/2 trial 2L cohort of ronde-cel in abstracts accepted for presentation at ASH 2026. The overall...

GlobeNewswire, Inc.

DT-216P2 Anticipated Milestones: Registrational Plan Update in Q4 2026 and 12-Week RESTORE-FA Data in Q1 2027 Cash and securities of $208.6 million at quarter-end provide strong financial runway CARLSBAD, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) --...

GlobeNewswire, Inc.

Advancing a neuromuscular franchise with claseprubart, a highly potent, investigational classical pathway inhibitor, with best-in-disease potential across generalized Myasthenia Gravis (gMG), Chronic Inflammatory Demyelinating Polyneuropathy...

GlobeNewswire, Inc.

Ribupatide oral global Phase 3 program expected to begin in 1H 2027 following completion of End-of-Phase 2 meeting with FDA Ribupatide injection Phase 2b trial and KaiNETIC global Phase 3 program fully enrolled; data expected mid-2027 and...

EIN Presswire

New consumer research reveals financial strain among Independents, growing spending cutbacks across political parties, & the potential influence of social media WORTHINGTON, OH, UNITED STATES, November 4, 2026 /⁨EINPresswire.com⁩/ -- Persistent...

GlobeNewswire, Inc.

-- Announces PANORAMA, an OnKure-sponsored, large-scale, multiregional registry designed to characterize the natural disease course and treatment patterns of people living with vascular anomalies -- Executing IND-enabling activities for...

GlobeNewswire, Inc.

PHILADELPHIA, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a precision guided, biotech/life sciences company focused on advancing the clinical development programs of novel and potentially...

GlobeNewswire, Inc.

3Q 2026 Total Revenue of $141.1 Million, Increasing 5% Year-over-Year 3Q 2026 ASCENIV Revenue of $124.7 Million, Increasing 31% Year-over-Year 3Q 2026 GAAP Net Income of $49.9 Million, Increasing 37% Year-over-Year 3Q 2026 Adjusted Net Income(1)...

EIN Presswire

The Business Research Company’s Lucentis (Ranibizumab) Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 LONDON, GREATER LONDON, UNITED KINGDOM, November 4, 2026 /⁨EINPresswire.com⁩/ -- The market for Lucentis (ranibizumab),...

EIN Presswire

A study of 88,000 Google reviews found owner replies doubled since 2019, and phrases typical of AI writing tools doubled after ChatGPT launched.

EIN Presswire

Social9's MCP connection gives AI assistants more than 60 tools to plan, write and schedule posts, with test mode and fact checks keeping a person in control SAN FRANCISCO, CA, UNITED STATES, November 4, 2026 /⁨EINPresswire.com⁩/ -- Social9, a...

North Carolina Department of Adult Correction

RE: Jimmy O. Stocks 0391422 COUNTY AND COURT: Wake County; Superior Court CRIME AND SENTENCE: 85 CRS 031602 First Degree Murder CONVICTION DATE: May 2, 1986 The North Carolina Post-Release Supervision and Parole Commission is notifying you that it...

U.S. Department of the Treasury

Network Circumvented Maritime Law to Enable Iran’s Shadow Fleet WASHINGTON—Today, as part of Operation Economic Outcast, the U.S. Department of the Treasury targeted the vast criminal network of India-based Suniel Kumar Sharma and his spouse,...